Top compounds associated with response to AC133551.1


Feature Type Standardized
Nominal ANOVA
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.076 0.02
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.082 0.02
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.088 0.02
mRNA pluripotin CTRPv2 pan-cancer AAC -0.082 0.02
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.02
mRNA ceranib-2 CTRPv2 pan-cancer AAC 0.076 0.02
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.11 0.02
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 0.03
mRNA PF-573228 CTRPv2 pan-cancer AAC -0.076 0.03
Download CSV